TrumpRx rollout mocked as critics torch math and fine print on drug price claims

Donald Trump billed the launch of TrumpRx as a historic breakthrough on drug prices, boasting it “should win us the midterms,” but the rollout quickly drew skepticism over exaggerated claims and sloppy math. While the new government website promotes discounted medications and coupons, critics zeroed in on Trump’s assertion that Ozempic prices were cut by “578%,” a figure economists and social media users swiftly debunked. Analysts also pointed to fine print showing the steepest discounts apply only temporarily to new patients, undercutting the president’s sweeping promises of lasting, transformative savings.

Watch the video below.

Your browser does not support the video tag. TrumpRx rollout mocked as critics torch math and fine print on drug price claims TrumpRx rollout mocked as critics torch math and fine print on drug price claims